Tag: biopharma leader
It’s a no go – Pfizer and Allergan will not merge
Last November, global biopharmaceutical giant Pfizer and Botox maker Allergan announced an all-stock $160 billion merger that would have resulted in the creation of...
Pfizer, Allergan merger to create the world’s biggest pharmaceutical company
Global biopharmaceutical giant Pfizer and Botox maker Allergan have announced an all-stock $160 billion merger that will result in the creation of the world’s...
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
